IRF1 and Alzheimer disease: To examine the expression level of IRF-1 in AD human brains, we compared frontal lobe samples with a short post-mortem delay (< 3 h) from ten Braak stage V and VI AD brains to ten age-matched control brains (Table S1) using western blot assay.